1. Home
  2. HTZ vs LQDA Comparison

HTZ vs LQDA Comparison

Compare HTZ & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTZ
  • LQDA
  • Stock Information
  • Founded
  • HTZ 1918
  • LQDA 2004
  • Country
  • HTZ United States
  • LQDA United States
  • Employees
  • HTZ N/A
  • LQDA N/A
  • Industry
  • HTZ Rental/Leasing Companies
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTZ Consumer Discretionary
  • LQDA Health Care
  • Exchange
  • HTZ Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • HTZ 2.4B
  • LQDA 2.5B
  • IPO Year
  • HTZ 1997
  • LQDA 2018
  • Fundamental
  • Price
  • HTZ $6.19
  • LQDA $25.00
  • Analyst Decision
  • HTZ Sell
  • LQDA Strong Buy
  • Analyst Count
  • HTZ 5
  • LQDA 9
  • Target Price
  • HTZ $4.43
  • LQDA $32.11
  • AVG Volume (30 Days)
  • HTZ 8.3M
  • LQDA 2.2M
  • Earning Date
  • HTZ 11-04-2025
  • LQDA 11-12-2025
  • Dividend Yield
  • HTZ N/A
  • LQDA N/A
  • EPS Growth
  • HTZ N/A
  • LQDA N/A
  • EPS
  • HTZ N/A
  • LQDA N/A
  • Revenue
  • HTZ $8,614,000,000.00
  • LQDA $19,322,000.00
  • Revenue This Year
  • HTZ N/A
  • LQDA $405.58
  • Revenue Next Year
  • HTZ $2.52
  • LQDA $373.93
  • P/E Ratio
  • HTZ N/A
  • LQDA N/A
  • Revenue Growth
  • HTZ N/A
  • LQDA 30.20
  • 52 Week Low
  • HTZ $2.77
  • LQDA $9.68
  • 52 Week High
  • HTZ $9.39
  • LQDA $29.94
  • Technical
  • Relative Strength Index (RSI)
  • HTZ 55.08
  • LQDA 45.82
  • Support Level
  • HTZ $5.98
  • LQDA $25.34
  • Resistance Level
  • HTZ $6.53
  • LQDA $28.00
  • Average True Range (ATR)
  • HTZ 0.35
  • LQDA 1.32
  • MACD
  • HTZ 0.10
  • LQDA -0.70
  • Stochastic Oscillator
  • HTZ 67.67
  • LQDA 0.50

About HTZ Hertz Global Holdings Inc

Hertz Global Holdings Inc is engaged principally in the business of renting vehicles through Hertz, Dollar and Thrifty brands. The Company has identified two reportable segments: Americas RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in the U.S., Canada, Latin America and the Caribbean; International RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in locations other than the U.S., Canada, Latin America and the Caribbean. The Company maintain a substantial network of company-operated rental locations, a majority of which are in Europe, and have franchisees and partners that operate rental locations under brands. Geographical markets includes U.S., Europe, Pacific Asia, Middle East and Africa, Latin America.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: